JP2005510539A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005510539A5 JP2005510539A5 JP2003546859A JP2003546859A JP2005510539A5 JP 2005510539 A5 JP2005510539 A5 JP 2005510539A5 JP 2003546859 A JP2003546859 A JP 2003546859A JP 2003546859 A JP2003546859 A JP 2003546859A JP 2005510539 A5 JP2005510539 A5 JP 2005510539A5
- Authority
- JP
- Japan
- Prior art keywords
- coating layer
- poly
- methacrylic acid
- methyl methacrylate
- inner coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011247 coating layer Substances 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 18
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 13
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 12
- 239000013543 active substance Substances 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000007892 solid unit dosage form Substances 0.000 claims 4
- 239000007888 film coating Substances 0.000 claims 3
- 238000009501 film coating Methods 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 claims 3
- 229960004963 mesalazine Drugs 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 229920002301 cellulose acetate Polymers 0.000 claims 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 2
- 229920000193 polymethacrylate Polymers 0.000 claims 2
- 239000007909 solid dosage form Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- 244000215068 Acacia senegal Species 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 235000003421 Plantago ovata Nutrition 0.000 claims 1
- 244000134552 Plantago ovata Species 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- -1 Propio Chemical class 0.000 claims 1
- 239000009223 Psyllium Substances 0.000 claims 1
- 229920001800 Shellac Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 229920002494 Zein Polymers 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- UTKBLLDLHPDWDU-ODZAUARKSA-N acetic acid;(z)-but-2-enedioic acid Chemical compound CC(O)=O.OC(=O)\C=C/C(O)=O UTKBLLDLHPDWDU-ODZAUARKSA-N 0.000 claims 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001088 anti-asthma Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 239000000924 antiasthmatic agent Substances 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000003908 antipruritic agent Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 239000002327 cardiovascular agent Substances 0.000 claims 1
- 229940125692 cardiovascular agent Drugs 0.000 claims 1
- 239000004203 carnauba wax Substances 0.000 claims 1
- 235000013869 carnauba wax Nutrition 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000007891 compressed tablet Substances 0.000 claims 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 239000008141 laxative Substances 0.000 claims 1
- 230000002475 laxative effect Effects 0.000 claims 1
- 229920003113 low viscosity grade hydroxypropyl cellulose Polymers 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 229940001470 psychoactive drug Drugs 0.000 claims 1
- 239000004089 psychotropic agent Substances 0.000 claims 1
- 229940070687 psyllium Drugs 0.000 claims 1
- 239000004208 shellac Substances 0.000 claims 1
- 229940113147 shellac Drugs 0.000 claims 1
- 235000013874 shellac Nutrition 0.000 claims 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- 239000005019 zein Substances 0.000 claims 1
- 229940093612 zein Drugs 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/043893 WO2003045356A1 (en) | 2000-11-20 | 2001-11-23 | Pharmaceutical dosage form with multiple coatings |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040514A Division JP2012107058A (ja) | 2012-02-27 | 2012-02-27 | 複数のコーティングを有する医薬剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005510539A JP2005510539A (ja) | 2005-04-21 |
| JP2005510539A5 true JP2005510539A5 (enExample) | 2005-12-22 |
| JP4999037B2 JP4999037B2 (ja) | 2012-08-15 |
Family
ID=32823137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546859A Expired - Lifetime JP4999037B2 (ja) | 2001-11-23 | 2001-11-23 | 複数のコーティングを有する医薬剤形 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1453487B2 (enExample) |
| JP (1) | JP4999037B2 (enExample) |
| CN (1) | CN1314390C (enExample) |
| AT (1) | ATE389389T1 (enExample) |
| AU (1) | AU2002226955B2 (enExample) |
| BR (1) | BRPI0117180B8 (enExample) |
| DE (1) | DE60133319T3 (enExample) |
| DK (1) | DK1453487T3 (enExample) |
| ES (1) | ES2301575T5 (enExample) |
| HU (1) | HU231030B1 (enExample) |
| IL (1) | IL161628A (enExample) |
| MX (1) | MXPA04004747A (enExample) |
| NZ (1) | NZ532564A (enExample) |
| PT (1) | PT1453487E (enExample) |
| WO (1) | WO2003045356A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
| CA2533577C (en) * | 2003-07-24 | 2014-10-21 | Smithkline Beecham Corporation | Orally dissolving films |
| GB2407501A (en) * | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell |
| US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| KR20080085924A (ko) * | 2004-09-01 | 2008-09-24 | 더 프록터 앤드 갬블 캄파니 | 5-아미노-2-하이드록시벤조산 및 환원당을 함유하는 조성물 |
| ATE512211T1 (de) | 2005-05-31 | 2011-06-15 | Iams Company | Feline probiotische lactobacilli |
| ES2607988T3 (es) | 2005-05-31 | 2017-04-05 | Iams Europe B.V. | Bifidobacterias probióticas felinas |
| ES2551719T3 (es) | 2007-02-01 | 2015-11-23 | Iams Europe B.V. | Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate |
| PT2152250T (pt) | 2007-05-07 | 2019-12-12 | Evonik Operations Gmbh | Formas farmacêuticas sólidas que compreendem um revestimento entérico com libertação acelerada do fármaco |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
| JP2012107058A (ja) * | 2012-02-27 | 2012-06-07 | Warner Chilcott Co Llc | 複数のコーティングを有する医薬剤形 |
| US20140141075A1 (en) * | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| GB2510754B (en) * | 2013-02-12 | 2016-07-13 | Diurnal Ltd | Controlled drug release |
| CA2901166C (en) * | 2013-02-22 | 2020-03-24 | Zeria Pharmaceutical Co., Ltd. | Enteric coated tablet |
| JP6165022B2 (ja) * | 2013-10-30 | 2017-07-19 | 株式会社ファンケル | 放出制御型ソフトカプセル剤 |
| WO2016001843A1 (en) * | 2014-06-30 | 2016-01-07 | Sun Pharmaceutical Industries Limited | Extended-release gastroretentive tablets of voglibose |
| EP3162362A1 (de) * | 2015-10-30 | 2017-05-03 | Dr. Falk Pharma Gmbh | Optimierte mesalazinhaltige hochdosistablette |
| CN107661370A (zh) * | 2017-11-20 | 2018-02-06 | 贵州浩诚药业有限公司 | 一种苦参片及其制备方法 |
| CN112105347A (zh) * | 2018-05-03 | 2020-12-18 | 兆瓦恩卡普有限公司 | 将药物递送至下消化道的剂型 |
| EP3613414A1 (de) | 2018-08-24 | 2020-02-26 | Dr. Falk Pharma Gmbh | Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon |
| WO2020229178A1 (en) * | 2019-05-15 | 2020-11-19 | Evonik Operations Gmbh | Process for preparing filled hard-shell capsules with (meth)acrylate copolymer based coatings with a capsule-filling machine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| CN1239425A (zh) * | 1996-11-15 | 1999-12-22 | 普罗克特和甘保尔公司 | 供结肠释放的具有多层肠溶聚合物包衣的药剂 |
| AU5310898A (en) * | 1996-12-20 | 1998-07-17 | Dumex-Alpharma A/S | Release-controlled coated tablets |
-
2001
- 2001-11-23 PT PT01995903T patent/PT1453487E/pt unknown
- 2001-11-23 DK DK01995903T patent/DK1453487T3/da active
- 2001-11-23 AT AT01995903T patent/ATE389389T1/de active
- 2001-11-23 AU AU2002226955A patent/AU2002226955B2/en not_active Expired
- 2001-11-23 CN CNB018238009A patent/CN1314390C/zh not_active Expired - Lifetime
- 2001-11-23 NZ NZ532564A patent/NZ532564A/en not_active IP Right Cessation
- 2001-11-23 BR BR0117180A patent/BRPI0117180B8/pt not_active IP Right Cessation
- 2001-11-23 ES ES01995903T patent/ES2301575T5/es not_active Expired - Lifetime
- 2001-11-23 WO PCT/US2001/043893 patent/WO2003045356A1/en not_active Ceased
- 2001-11-23 MX MXPA04004747A patent/MXPA04004747A/es active IP Right Grant
- 2001-11-23 DE DE60133319.5T patent/DE60133319T3/de not_active Expired - Lifetime
- 2001-11-23 HU HU0402230A patent/HU231030B1/hu unknown
- 2001-11-23 JP JP2003546859A patent/JP4999037B2/ja not_active Expired - Lifetime
- 2001-11-23 EP EP01995903.0A patent/EP1453487B2/en not_active Expired - Lifetime
-
2004
- 2004-04-26 IL IL161628A patent/IL161628A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005510539A5 (enExample) | ||
| JP4999037B2 (ja) | 複数のコーティングを有する医薬剤形 | |
| AU654277B2 (en) | Controlled release drug formulation | |
| CN1404389B (zh) | 时控脉冲给药系统 | |
| US5686105A (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| EP0827398B1 (en) | Pharmaceutical dosage form for colonic delivery | |
| CN102970983B (zh) | 耐受酒精的口服药物制剂 | |
| JPH10203983A5 (enExample) | ||
| JP2001509157A (ja) | 時間特異的放出制御型投与製剤及びその製法 | |
| JP2792904B2 (ja) | 有効物質を制御して放出する経口投与用の薬学的製剤、及びその製造方法 | |
| JP2003530423A5 (enExample) | ||
| JP2017532363A5 (enExample) | ||
| JP2009512699A5 (enExample) | ||
| KR20070069105A (ko) | 서방성 제제 | |
| JP5674671B2 (ja) | 塩酸シプロヘプタジン軟膏剤及びその製造方法 | |
| EP1283701A1 (en) | A coating composition for facilitating controlled release | |
| HK1214136A1 (zh) | 硝酸氨基烷基酯的延长释放组合物 | |
| WO2009006299A2 (en) | Multi-particulate systems | |
| WO1998022096A1 (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| CN104856971B (zh) | 一种脉冲双释放制剂及其制备方法与应用 | |
| JP2003510347A (ja) | 抗炎症医薬品製剤 | |
| WO2006117803A2 (en) | Transmucosal drug delivery systems | |
| CN101530387B (zh) | 口服迟释药物制剂 | |
| CN101259112A (zh) | 盐酸沙格雷酯单层渗透泵控释制剂及其制备方法 | |
| JP2012107058A (ja) | 複数のコーティングを有する医薬剤形 |